Document is current

Any future updates will be listed below

Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab

Crossref DOI link: https://doi.org/10.1007/s10620-021-06852-3

Published Online: 2021-02-11

Published Print: 2021-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark